Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Recruiting now · Phase 4
Conditions studied: Venous Leg Ulcer, Venous Leg, Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer, Diabetic, Ulcer Foot, Leg Ulcer, Ulcer Venous, Ulcer
In brief
Title A Multicenter, Prospective, Randomized Controlled Modified Multi-Platform (Matriarch) Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care versus Standard of Care alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
Key facts
- Study ID
- NCT06826339
- Run by
- Tiger Biosciences, LLC.
- People needed
- 340
- Starts
- 2024-12-06
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2025-02-13
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Serena Group — Monroeville, Pennsylvania, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.